Lyell Immunopharma, Inc. - Common Stock (NQ:LYEL)

14.86 -0.14 (-0.93%)

Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lyell Immunopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy ↗

October 30, 2024

Lyell Immunopharma acquires ImmPACT Bio, ends TIL programs, and refocuses on CAR T-cell research. Analyst downgrades reflect concerns over pipeline complexities.

Via Benzinga

Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

October 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 24, 2024

Via Benzinga

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

October 24, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 04, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

September 24, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Announces Participation in September Investor Conferences

August 28, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday ↗

August 19, 2024

Via Benzinga

LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q2 2024 ↗

August 08, 2024

LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

August 07, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

3 Biotech Stocks to Sell in August Before They Crash & Burn ↗

August 06, 2024

Investors should keep a watchful eye out for these three biotech stocks to sell before a potential dip damages their gains.

Via InvestorPlace

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial ↗

June 26, 2024

Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed CAR T-cell product. The company reported some severe cases reported in...

Via Benzinga

Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology

June 26, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference

June 03, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma to Participate in BofA Securities Health Care Conference

May 07, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024 ↗

May 06, 2024

LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

May 06, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 16, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

Via Benzinga

Topics Stocks

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 12, 2024

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Via Benzinga

Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday ↗

April 12, 2024

U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected...

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 12, 2024

Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 11, 2024

Via Benzinga

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday ↗

April 09, 2024

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.

Via Benzinga

Topics Stocks

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 09, 2024

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

Via Benzinga

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting

March 05, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday ↗

March 04, 2024

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

Via Benzinga

Topics Stocks

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023

February 28, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma Announces Participation in March Investor Conferences

February 26, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Lyell Immunopharma, Inc

Via GlobeNewswire

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.